St. Jude finds young age may give survival advantage to children with certain brain tumorsMay 30, 2008The improved survival of children under 3 years old with diffuse pontine glioma compared to older children suggests that the biological properties of this cancer may be distinct in young patients St. Jude Children's Research Hospital investigators have shown that children under 3 years old who have a brain tumor called diffuse pontine glioma (DPG) appear to have a better outcome than older children with the same cancer. Results of the study, which appear in the advance online publication of the journal "Cancer," are important because clinicians have long believed that DPG was universally fatal. Moreover, it was assumed that clinicians had simply misdiagnosed the disease in children who responded to treatment and survived.
"Our findings show that children under 3 years with DPG can potentially respond better to treatment than older children," said Alberto Broniscer, M.D., assistant member in the St. Jude Department of Oncology and the paper's first author. "Unlike other previous studies in young children where the diagnosis of DPG was based on either CT scans or magnetic resonance imaging (MRI), the diagnosis of all our patients was based on MRI only. CT scans are not able to differentiate between DPG-a tumor that occurs in the brainstem-and other tumors, which originate in the same area with a better prognosis." The researchers reviewed the medical records of 10 patients under 3 years of age with DPG. The median age of these patients was 2.2 years, and the median time between symptom development and actual diagnosis was 2.5 months. All children had the diagnosis of DPG based on radiological review of their MRIs at diagnosis. All of the children received treatment-two with radiation, six with radiation plus chemotherapy, and two with chemotherapy only. Four of the children died, but six have survived for at least two years following this therapy, which is ineffective in older children with similar tumors. Based on these findings, the St. Jude team calculates that 45 percent of children under 3 years treated for DPG will survive for at least three years without experiencing tumor growth, and 69 percent of such children will survive. From these results, the investigators concluded that distinct biological characteristics of DPG in children under 3 years compared to older children might account for their better response to radiation and chemotherapy. The researchers point to a similar finding with a type of glioma that originates in the cerebrum: Young children with high-grade gliomas originating in the cerebrum seem to have a better prognosis when compared to older children. Different biological properties also seem to play a role in the latter case. Brainstem gliomas account for 10 to 15 percent of all brain tumors in children; and DPGs account for 80 percent of brainstem tumors in childhood. Although MRI revolutionized the diagnosis of DPG, no significant improvements have occurred in its treatment in children during the past 20 years, according to St. Jude researchers. The long-term survival of children with DPG has remained less than 10 percent despite treatment with radiation and chemotherapy. The St. Jude team is now collecting tumor samples and performing extensive molecular analyses in order to gain a better understanding of the biology of DPGs in children. "We believe that the more we learn about DPGs, the more likely we will be able to design more effective treatments for children of all ages with this tumor," Broniscer said. St. Jude Children's Research Hospital Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Allergies Tobacco Asthma Tumor Cells Ultrasound Elephants Fragile X Syndrome Cardiovascular Risk Mathematics Ageing Oxidative Stress Penguins Curcumin Colon Cancer Herpes Solar Cell Rem Sleep Flowering Plants Hypoxia Dendritic Cells Influenza Pandemic Staph Infection Omega-3 Fatty Acids Hearing Loss Meditation
See More: Science News Tags | |||||||||||||||||||||
|
Related Brain Tumor Current Events and Brain Tumor News Articles UAB Researchers Draft 3-D Protein Map A new three-dimensional computer protein map is helping researchers at the University of Alabama at Birmingham (UAB) unravel the biological pathways that control brain-cell death after a stroke. Tumor suppressor gene in flies may provide insights for human brain tumors In the fruit fly's developing brain, stem cells called neuroblasts normally divide to create one self-renewing neuroblast and one cell that has a different fate. But neuroblast growth can sometimes spin out of control and become a brain tumor. Potential for noninvasive brain tumor treatment Duke University engineers have taken a first step toward a minimally invasive treatment of brain tumors by combining chemotherapy with heat administered from the end of a catheter. Study Finds Needle Biopsies Safe in 'Eloquent' Areas of Brain After a review of 284 cases, specialists at the Brain Tumor Center at the University of Cincinnati (UC) Neuroscience Institute have concluded that performing a stereotactic needle biopsy in an area of the brain associated with language or other important functions carries no greater risk than a similar biopsy in a less critical area of the brain. Automated analysis of MR images may identify early Alzheimer's disease Analyzing MRI studies of the brain with software developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) may allow diagnosis of Alzheimer's disease and of mild cognitive impairment, a lesser form of dementia that precedes the development of Alzheimer's by several years. Computer Model Predicts Brain Tumor Growth and Evolution Researchers from Brown University and other institutions have developed a computational computer model of how brain tumors grow and evolve. Lithium may help radiation target cancer, spare healthy tissue Vanderbilt-Ingram Cancer Center investigators have uncovered a mechanism that helps explain how lithium, a drug widely used to treat bipolar mood disorder, also protects the brain from damage that occurs during radiation treatments. New imaging analysis predicts brain tumor survival As early as one week after beginning treatment for brain tumors, a new imaging analysis method was able to predict which patients would live longer, researchers from the University of Michigan Comprehensive Cancer Center have found. Brain metastases hijack neuron-supporting cells to resist chemotherapy Cancer that spreads to other organs finds a particularly inviting hideout in the brain, where these metastases are usually far harder to treat than they are in other locations. Reversing effects of altered enzyme may fight brain tumor growth An international team of scientists from the Moores Cancer Center at the University of California, San Diego, the University of North Carolina and several institutions in China have explained how a gene alteration can lead to the development of a type of brain cancer, and they have identified a compound that could staunch the cancer's growth. More Brain Tumor Current Events and Brain Tumor News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||